Canada markets closed

Seelos Therapeutics, Inc. (NXE0.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.00000.0000 (0.00%)
At close: 08:01AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
27,974
30,117
58,620
46,649
10,984
Selling General and Administrative
11,622
12,585
12,296
15,020
7,775
Total Operating Expenses
37,622
40,499
70,916
61,669
18,759
Operating Income or Loss
-37,622
-40,499
-70,916
-61,669
-18,759
Interest Expense
91
75
14
1,598
164
Total Other Income/Expenses Net
10,457
2,494
-2,725
-2,894
-223
Income Before Tax
-27,115
-37,882
-73,534
-66,048
-19,101
Income from Continuing Operations
-27,115
-37,882
-73,534
-66,048
-19,101
Net Income
-27,115
-37,882
-73,534
-66,048
-19,101
Net Income available to common shareholders
-27,115
-37,882
-73,534
-66,048
-19,101
Basic EPS
-12.90
-61.84
-165.92
-175.20
-103.20
Diluted EPS
-12.90
-61.84
-165.92
-175.20
-103.20
Basic Average Shares
4,059
612.527
443.211
378.708
186.527
Diluted Average Shares
4,059
612.527
443.211
378.708
186.527